A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens.

Por Louis, D. N., von Deimling, A., Seizinger, B. R.
Publicado em 1992

Investigation of germline GFRα-1 mutations in Hirschsprung disease

Por Myers, S., Salomon, R., Goessling, A., Pelet, A., Eng, C., von Deimling, A., Lyonnet, S., Mulligan, L.
Publicado em 1999

Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.

Por Koopmann, J., Maintz, D., Schild, S., Schramm, J., Louis, D. N., Wiestler, O. D., von Deimling, A.
Publicado em 1995

OS07.1 Molecular differences in IDH wild type glioblastoma according to MGMT promoter methylation status

Por Kessler, T., Sahm, F., Sadik, A., Hertenstein, A., Bendszus, M., von Deimling, A., Platten, M., Wick, W.
Publicado no Neuro Oncol (2017)

P04.22 OLIGOASTROCYTOMA DOES NOT EXIST: A MOLECULAR GENETIC REAPPRAISAL ON SINGLE-CELL LEVEL

Por Sahm, F., Reuss, D., Koelsche, C., Schittenhelm, J., Heim, S., Herold-Mende, C., Paulus, W., von Deimling, A.
Publicado em 2014

Rint1 inactivation triggers genomic instability, ER stress and autophagy inhibition in the brain

Por Grigaravicius, P, Kaminska, E, Hübner, C A, McKinnon, P J, von Deimling, A, Frappart, P-O
Publicado no Cell Death Differ (2016)

P09.18 Location-dependent prognostic factors and recurrence patterns in IDH wildtype glioblastoma

Por Jungk, C., Warta, R., Mock, A., Hug, B., Bendszus, M., von Deimling, A., Unterberg, A., Herold-Mende, C.
Publicado no Neuro Oncol (2017)

P02.03 Multiple sclerosis and gliomas - a coincidence?

Por Ochs, K., Capper, D., Sahm, F., Jones, D. T. W., Schrimpf, D., von Deimling, A., Wick, W., Platten, M.
Publicado no Neuro Oncol (2016)

P08.76 Anti-EGFL7 treatment as an add-on for glioma therapy

Por Dudvarski Stanković, N., Jones, D., Harter, P. N., von Deimling, A., Mittelbronn, M., Pfister, S., Schmidt, M. H. H.
Publicado no Neuro Oncol (2016)

O6.09 PROSTAGLANDIN E RECEPTOR-4 ACTIVATION REGULATES TRYPTOPHAN METABOLISM IN HUMAN MALIGNANT GLIOMAS

Por Ochs, K., Ott, M., Rauschenbach, K.J., Sahm, F., Opitz, C.A., von Deimling, A., Wick, W., Platten, M.
Publicado em 2014

O6.06 PERIPHERAL T CELL RESPONSES IN GLIOBLASTOMA PATIENTS ARE ASSOCIATED WITH AN IMPROVED SURVIVAL

Por Herold-Mende, C.C., Mossemann, J., Jungk, C., Ahmadi, R., Unterberg, A., Capper, D., vonDeimling, A., Beckhove, P.
Publicado em 2014

OS6.1 Molecular characterization of astroblastoma

Por Antonelli, M., Sturm, D., Jones, D. T., von Deimling, A., Korshunov, A., Kool, M., Pfister, S. M., Giangaspero, F., Capper, D.
Publicado no Neuro Oncol (2016)

Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease

Por Gath, R, Goessling, A, Keller, K, Koletzko, S, Coerdt, W, Muntefering, H, Wirth, S, Hofstra, R, Mulligan, L, Eng, C, von Deimling, A
Publicado em 2001

PROX1 is a predictor of survival for gliomas WHO grade II

Por Elsir, T, Qu, M, Berntsson, S G, Orrego, A, Olofsson, T, Lindström, M S, Nistér, M, von Deimling, A, Hartmann, C, Ribom, D, Smits, A
Publicado em 2011

Molecular genetic analysis of giant cell glioblastomas.

Por Meyer-Puttlitz, B., Hayashi, Y., Waha, A., Rollbrocker, B., Boström, J., Wiestler, O. D., Louis, D. N., Reifenberger, G., von Deimling, A.
Publicado em 1997

O10.01 PROGNOSTIC AND PREDICTIVE BIOMARKER-BASED SUBGROUPS IN THE NOA-04 TRIAL

Por Wick, W., Capper, D., Sill, M., Hovestadt, V., Pfister, S.M., Platten, M., Reifenberger, G., von Deimling, A., Weller, M., Wiestler, B.
Publicado em 2014

P06.06 A mutation-specific vaccine for Histone-3 K27M-mutated gliomas

Por Ochs, K., Ott, M., Bunse, T., Sahm, F., Bunse, L., Keil, M., Deumelandt, K., Sonner, J., von Deimling, A., Wick, W., Platten, M.
Publicado no Neuro Oncol (2017)

P08.48 Combined alterations in MAPK pathway genes, CDKN2A/B and ATRX characterize anaplastic pilocytic astrocytoma

Por Kratz, A., Sahm, F., Schrimpf, D., Jones, D. T., Reuss, D. E., Schittenhelm, J., Gramatzki, D., Felsberg, J., von Deimling, A., Capper, D.
Publicado no Neuro Oncol (2016)

P09.09 Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas

Por Sahm, F., Korshunov, A., Jones, D. T. W., Paulus, W., Herold-Mende, C., Unterberg, A., Pfister, S. M., Brandner, S., Wick, W., von Deimling, A.
Publicado no Neuro Oncol (2016)

OS6.4 Molecular classification of meningiomas across all histological subtypes and grades

Por Sahm, F., Jones, D. T. W., Mittelbronn, M., Weller, M., Paulus, W., Wick, W., Unterberg, A., Herold-Mende, C., Pfister, S. M., von Deimling, A.
Publicado no Neuro Oncol (2016)